Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 2, 2009, Pages 257-265

  Huang, Xiao Jun ^a   Liu, Dai Hong ^a   Liu, Kai Yan ^a   Xu, Lan Ping ^a   Chen, Huan ^a   Han, Wei ^a   Chen, Yu Hong ^a   Zhang, Xiao Hui ^a   Lu, Dao Pei ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Acute leukemia; Blood and marrow transplantation; Haploidentical; HLA mismatched

Indexed keywords

ACICLOVIR; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DACLIZUMAB; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; HLA A ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SANGSTAT; SEMUSTINE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER SURVIVAL; CANDIDIASIS; CHILD; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DONOR LYMPHOCYTE INFUSION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HAPLOIDY; HERPES; HERPES ZOSTER; HIGH RISK PATIENT; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; LEUKEMIA RELAPSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; RISK ASSESSMENT;

ACUTE DISEASE; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58249132219     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.11.025     Document Type: Article

References (26)

1. Horowitz M.M., Gale R.P., Sondel P.M., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75 (1990) 555-562
2. Ottinger H.D., Ferencik S., Beelen D.W., et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 102 (2003) 1131-1137
3. Benito A.I., Diaz M.A., Gonzalez-Vicent M., et al. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 33 (2004) 675-690
4. Aversa F., Tabilio A., Velardi A., et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with 1 fully mismatched HLA haplotype. N Engl J Med 339 (1998) 1186-1193
5. Aversa F., Terenzi A., Felicini R., et al. Haploidentical stem cell transplantation for acute leukemia. Int J Hematol 7 Suppl (2002) 165-168
6. Aversa F., and Martelli M.F. Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases. Springer Semin Immunopathol 26 (2004) 155-168
7. Kodera Y., Nishida T., Ichinohe T., and Saji H. Human leukocyte antigen haploidentical hematopoietic stem cell transplantation; indications and tentative outcomes in Japan. Semin Hematol 42 (2005) 112-118
8. Huang X.J., Liu D.H., Liu K.Y., et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological disease. Bone Marrow Transplant 38 (2006) 291-297
9. Liu Y., Chen S., and Yu H. [Standardization and quality control in flow cytometric enumeration of CD34(+) cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 8 (2000) 302-306
10. Huang X.J., Jiang Q., Chen H., et al. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 36 (2005) 343-348
11. Huang X.J., Liu D.H., Liu K.Y., et al. Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation. Haematologica 92 (2007) 414-417
12. Huang X.J., Liu D.H., Liu K.Y., et al. Donor lymphocyte infusion after HLA-mismatched/habloidentical T-cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia. J Clin Immunol 28 (2008) 276-283
13. Meyers J.D., Flournoy N., and Thomas E.D. Nonbacterial pneumonia after allogeneic marrow transplantation. A review of ten years' experience. Rev Infect Dis 4 (1982) 1119-1132
14. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15 (1995) 825-828
15. Rowlings P.A., Przepiorka D., Klein J.P., et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 97 (1997) 855-864
16. Chang Y.J., Zhao X.Y., and Huang X.J. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies. Biol Blood Marrow Transplant 14 (2008) 323-334
17. Lu D.P., Dong L.J., Wu T., et al. Conditioning including antithymocyte HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 107 (2006) 3065-3073
18. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
19. Brensinger W.I., Clift R.A., Applebaum F.A., et al. Transplantation of allogeneic peripheral stem cells mobilized by recombinant human granulocyte-colony stimulating factor. Stem Cells 14 (1996) 90
20. Elfenbein G.J., and Sackatein R. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow. Exp Hematol 32 (2004) 327-339
21. Huang X.J., Chang Y.J., and Zhao X.Y. A direct comparison of immunological characteristics of granulocyte-colony stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts. Hematologica 90 (2005) 715-716
22. Huang X.-J., Chang Y.-J., and Zhao X.-Y. Mainitaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportion. Transplant Immunol 17 (2007) 193-197
23. Beatty P., Clift R., Mickelson E., et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313 (1985) 765-771
24. Szydlo R., Goldman J., Klein J., et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 15 (1997) 1767-1777
25. Rizzieri D.A., Koh L.P., Long G.D., et al. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol 25 (2007) 690-697
26. Waller E.K., Langston A.A., Lonial S., et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant 9 (2003) 460-471